Client & task
In 2019, Novartis Pharmaceuticals acquired Xiidra, a first-in-class treatment for dry eyes. The COVID-19 pandemic posed a significant challenge to the relaunch of Xiidra in the United States, as traditional in-person marketing tactics were limited. To overcome this hurdle, Novartis partnered with Digital Opinion Leader.
The Results
The relaunch of Xiidra was a resounding success, with the campaign generating over $250 million in sales in the first year. The “Dry Eye” animated character played a significant role in enhancing patient engagement and understanding of the condition.
The partnership between Novartis and Digital Opinion leader demonstrated the effectiveness of leveraging a combination of traditional and innovative marketing strategies to drive successful product launches. By incorporating the “Dry Eye” animated character into the campaign, Novartis was able to make the concept of dry eye more relatable and engaging for patients.
45%
Increase in
market share
10k+
HCPs & Patients Engaged
The Xiidra project was a great opportunity to relaunch a successful brand with the help of a celebrity DOL. We were able to leverage our full DOL Catalyst program. We thank the Novartis brand team for their partnership and trust.
CEO of Digital Opinion Leader
